Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes

Abstract

Objectives: To perform an audit of empirical antibiotic therapy (EAT) of sepsis at the emergency de-partment and to analyse the impact of an antimicrobial stewardship (AMS) programme on process and patient outcomes. Patients and Methods: A prospective, single-centre cohort study including patients with sequential or-gan failure assessment (SOFA) score >= 2 from whom blood cultures were taken was conducted between February 2019 and April 2020. EAT was assessed using eight applicable inpatient quality indicators (IQIs) for responsible antibiotic use. Patient outcomes were hospital length-of-stay (LOS), ICU admission, ICU LOS, and in-hospital mortality. Results: The audit included 900 sepsis episodes in 803 patients. Full guideline adherence regarding choice and dosing was 45.9%; adherence regarding choice alone was 68.1%. EAT was active against all likely pathogens in 665/787 (84.5%) episodes. In the guideline non-adherent group, choice of EAT was inappro-priate in 122/251 (48.6%) episodes. Changes within 3 days occurred in 335/900 (37.2%) episodes. Treating physicians changed administration route more often, whereas microbiological/infectious disease (ID)/AMS consultant advice resulted in de-escalation and discontinuation ( P = 0.0 0 0). Guideline-adherent choice was associated with significantly shorter LOS (6 (4-11) vs. 8 (5-15) days). Full adherence was associated with significantly lower mortality (23 (6.4%) vs. 48 (11.3%)) and shorter LOS (6 (4-10) vs. 8 (5-14) days). Conclusion: Five global quality indicators of EAT were measurable in routine clinical practice. Full ad-herence to guidelines was only moderate. Adherence to guidelines was associated with better patient outcomes. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )